Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy in Patients With Advanced Stage, Asymptomatic, Non-Bulky Follicular Lymphoma

NCT00112931 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT00112931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00112931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy in Patients With Advanced Stage, Asymptomatic, Non-Bulky Follicular Lymphoma
Lead sponsor
University College, London
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2004
Completion date
September 14, 2023
Enrollment
462 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma